These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 15193840)

  • 1. MOONLIGHT: a controlled registry of an iridium oxide-coated stent with angiographic follow-up.
    Di Mario C; Grube E; Nisanci Y; Reifart N; Colombo A; Rodermann J; Muller R; Umman S; Liistro F; Montorfano M; Alt E
    Int J Cardiol; 2004 Jun; 95(2-3):329-31. PubMed ID: 15193840
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness and safety of the sirolimus-eluting stents coated with bioabsorbable polymer coating in human coronary arteries.
    Ge J; Qian J; Wang X; Wang Q; Yan W; Yan Y; Fan B; Ge L; Liu X
    Catheter Cardiovasc Interv; 2007 Feb; 69(2):198-202. PubMed ID: 17195205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lunar stent characteristics and clinical results.
    Sgura FA; Di Mario C; Liistro F; Montorfano M; Colombo A; Grube E
    Herz; 2002 Sep; 27(6):514-7. PubMed ID: 12378396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel paclitaxel-eluting, biodegradable polymer coated stent in the treatment of de novo coronary lesions: a prospective multicenter registry.
    Buszman P; Trznadel S; Milewski K; Rzeźniczak J; Przewłocki T; Kośmider M; Wójcik J; Janczak J; Zurakowski A; Kondys M; Król M; Kinasz L; Jaklik A; Rzeszutko Ł; Kałuza GL; Kiesz S; Gil R
    Catheter Cardiovasc Interv; 2008 Jan; 71(1):51-7. PubMed ID: 18098182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry--STENT Group.
    Simonton CA; Brodie B; Cheek B; Krainin F; Metzger C; Hermiller J; Juk S; Duffy P; Humphrey A; Nussbaum M; Laurent S;
    J Am Coll Cardiol; 2007 Sep; 50(13):1214-22. PubMed ID: 17888837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of stent fracture as a cause of coronary restenosis after sirolimus-eluting stent implantation.
    Lee SH; Park JS; Shin DG; Kim YJ; Hong GR; Kim W; Shim BS
    Am J Cardiol; 2007 Aug; 100(4):627-30. PubMed ID: 17697818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
    Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian multicenter registry).
    Yan BP; Duffy SJ; Clark DJ; Lefkovits J; Warren R; Gurvitch R; Lew R; Sebastian M; Brennan A; Andrianopoulos N; Reid CM; Ajani AE;
    Am J Cardiol; 2008 Jun; 101(12):1716-22. PubMed ID: 18549846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of clinical and angiographic outcomes after Excel bioabsorbable polymer versus Firebird durable polymer rapamycin-eluting stent for the treatment of coronary artery disease in a "real world" setting: six-month follow-up results.
    Liu HB; Xu B; Qiao SB; Yang YJ; Ma WH; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Li JJ; Chen JL; Gao RL
    Chin Med J (Engl); 2007 Apr; 120(7):574-7. PubMed ID: 17442205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.
    Ajani AE; Yan BP; Clark DJ; Eccleston D; Walton A; Lew R; Meehan A; Brennan A; Reid C; Duffy SJ;
    Heart Lung Circ; 2007 Aug; 16(4):269-73. PubMed ID: 17419097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Coroflex Theca-Stent for reduction of restenosis (ECORI).
    Unverdorben M; Degenhardt R; Sick P; Kastrati A; Desmet W; Colombo A; Garcia E; Klein W; Wagner E; Köhler H; Scholz M; Berthold HK; Vallbracht C
    J Invasive Cardiol; 2005 Apr; 17(4):199-202. PubMed ID: 15831972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized comparison of carbon ion-implanted stent versus bare metal stent in coronary artery disease: the Asian Pacific Multicenter Arthos Stent Study (PASS) trial.
    Kim YH; Lee CW; Hong MK; Park SW; Tahk SJ; Yang JY; Saito S; Santoso T; Quan L; Ge J; Weissman NJ; Lansky AJ; Mintz GS; Park SJ
    Am Heart J; 2005 Feb; 149(2):336-41. PubMed ID: 15846274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nude stents, coated stents].
    Puel J
    Bull Acad Natl Med; 2005 Feb; 189(2):237-47. PubMed ID: 16114855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.
    Kollum M; Farb A; Schreiber R; Terfera K; Arab A; Geist A; Haberstroh J; Wnendt S; Virmani R; Hehrlein C
    Catheter Cardiovasc Interv; 2005 Jan; 64(1):85-90. PubMed ID: 15619311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetramethylpyrazine-eluting stents prevented in-stent restenosis in a porcine model.
    Ma G; Ding S; Feng Y; Shen C; Chen L; Chen Z
    J Cardiovasc Pharmacol; 2007 Aug; 50(2):201-5. PubMed ID: 17703137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic total occlusion due to diffuse in-stent restenosis: is brachytherapy the solution?
    Nikolsky E; Gruberg L; Rosenblatt E; Grenadier E; Boulos M; Bernstein Z; Huber A; Gitman R; Bar-Deroma R; Markiewicz W; Beyar R
    Int J Cardiovasc Intervent; 2004; 6(1):33-8. PubMed ID: 15204171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiographic follow-up of genous bioengineered stent in acute myocardial infarction (GENAMI)-a pilot study.
    Kaul U; Bhatia V; Ghose T; Gupta R; Kachru R; Singh G
    Indian Heart J; 2008; 60(6):532-5. PubMed ID: 19276491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and predictors of recurrent restenosis following implantation of drug-eluting stents for in-stent restenosis.
    Lee CW; Park CB; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):104-8. PubMed ID: 17139669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.